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AbsTrACT
Introduction Advanced bleeding control options for 
truncal and junctional haemorrhage including resuscita-
tive endovascular balloon occlusion of the aorta (REBOA) 
have been used in managing catastrophic bleeding. 
The primary aim is to report on potential indications for 
advanced bleeding control in combat casualties during 
the Dutch deployment in Uruzgan, Afghanistan, between 
August 2006 and August 2010. The secondary aim is to 
report on training methods for advanced bleeding control 
in (para)medical personnel.
Methods The trauma registry from the Dutch role 
2 enhanced medical treatment facility at Tarin Kowt, 
Uruzgan, Afghanistan, was used to analyse patients who 
sustained a battle injury with major haemorrhage. Further-
more, a comprehensive search was performed on training 
(para)medical personnel in advanced bleeding control.
results There were 212 possible indications for 
advanced bleeding control with mortality of 28.8% 
(61/212). These possible indications consisted of 1.9% 
(4/212) junctional lower extremity injuries with a 75% 
(3/4) mortality rate, 59% (125/212) visceral vascular inju-
ries with a mortality rate of 12.5% (26/125). The junc-
tional and visceral injuries (n=129) were all potential 
indications for advanced bleeding control options, such as 
REBOA. Further 39.2% (83/212) casualties with central 
thoracic or neck injuries had a mortality rate of 38.6% 
(32/83). Based on an Abbreviated Injury Scale chest or 
abdomen score ≥461 indications for advanced bleeding 
control were identified. A 24-hour average of 8.8 packets 
of red blood cells, 4.2 packets of plasma and 1.9 packets 
of platelets was used to prevent exsanguination. The total 
out-of-hospital survival rate was 64% (39/61).
Conclusion Retrospective analysis revealed 212 poten-
tial indications for advanced bleeding control with a 
mortality of 28.8% (61/212). Advanced bleeding control, 
such as REBOA, might have improved survival in approx-
imately 61 of 212 casualties. Advanced bleeding control 
could be used as an adjunct to improve outcomes in major 
truncal or junctional haemorrhage in prehospital, remote 
settings and implementation should be considered. 
Vascular access training and REBOA placement for (para)
medical military personnel should be explored in future 
research.
InTrOduCTIOn
Controlling catastrophic bleeding is the major 
life-saving skill in trauma and vascular surgery. 
In catastrophic bleeding cases advanced bleeding 
options for truncal and junctional haemorrhage 
include wound clamps, injectable haemostatic 
sponges, Foley catheter balloon tamponade, pelvic 
circumferential stabilisers, resuscitative thora-
cotomy, intra-abdominal gas insufflation, intra-ab-
dominal self-expanding foam, junctional and 
truncal tourniquets and resuscitative endovascular 
balloon occlusion of the aorta (REBOA).1 Although 
REBOA has been used as part of the endovascular 
and hybrid trauma and bleeding management 
concept in patients with non-compressible truncal 
and junctional injuries involving massive haem-
orrhage, implementation of REBOA in civilian or 
military setting for combat casualties has not been 
widely adopted.2–4 In 2012, Eastridge et al reviewed 
US battlefield fatalities (2001–2011) and classified 
24.3% (n=976) as potentially survivable, with fatal 
injuries predominantly related to haemorrhage.5 
The lag in implementation of advanced bleeding 
control options such as REBOA could be secondary 
to a possible underestimation of the potential indi-
cations for advanced bleeding control, or the lack 
of skills in first responders.
The primary aim of this paper is to report on the 
potential indications for advanced bleeding control 
options in combat casualties during the Dutch 
deployment in Uruzgan, Afghanistan, between 
2006 and 2010. The secondary aim is to report on 
possible training methods for advanced bleeding 
control such as vascular access and REBOA place-
ment, in medical and paramedical personnel to 
improve outcome after major haemorrhage.
MeThOds
The trauma registry from the Dutch role 2 enhanced 
medical treatment facility (R2E MTF) at the multi-
national base Tarin Kowt, Uruzgan, Afghanistan, 
was used to identify and analyse patients who 
sustained a battle injury with major haemorrhage 
during the Dutch deployment between August 
2006 and August 2010. We selected severe pelvic/
junctional/femoral injuries with an Abbreviated 
Injury Scale (AIS) score ≥4 for this analysis. Casu-
alties with extremity injuries scoring ≥4 on the 
AIS are likely to sustain severe to critical bleeding. 
Haemorrhage control using a tourniquet is often 
not adequate in these severe injuries, often being a 
mangled extremity or a traumatic amputation well 
above the knee or at the pelvic level. A second anal-
ysis was performed using the data of the combined 
battlefield casualties and military blood bank data-
base. The Abbreviated Injury Scale (AIS) and (New) 
Injury Severity Score (N)ISS,6–8 combined with the 
administration of packed blood products, were 
used to optimise the analysis for potential REBOA 
indications.
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Table 1A Potential indication for advanced bleeding control/
REBOA—bleeding sites
bleeding site n survival, n (%)
Junctional lower extremity 4 3 (25)
Visceral vascular 125 99 (79.2)
Central thoracic or neck 83 51 (61.4)
Total 212 153 (72.1)
REBOA, resuscitative endovascular balloon occlusion of the aorta.
Table 1b Potential indication for advanced bleeding control/REBOA—injury severity
Indication n Iss mean (sd) Iss median (IQr) nIss mean (sd) nIss median (IQr) survival, n (%)
AIS chest ≥4 14 24.6 (9.3) 25 (17–25) 29.8 (10.4) 29 (23–36) 10 (71)
AIS abdomen ≥4 34 21.8 (7.8) 17.5 (16–26) 29.5 (8.3) 32 (24–34) 19 (56)
AIS extremity ≥4 15 21.2 (6.8) 16 (16–26) 29.1 (7.5) 26 (25–34) 11 (73)
Total 61* 21.5 (6.9) 18 (16–25) 29.0 (8.1) 29 (25–34) 39 (64)
*Two patients had combined AIS chest and AIS abdomen ≥4.
AIS, Abbreviated Injury Scale; ISS, Injury Severity Score; NISS, New Injury Severity Score; REBOA, resuscitative endovascular balloon occlusion of the aorta.
Statistical analyses were performed using the Statistical 
Package for the Social Sciences (SPSS, V.24, IBM). Furthermore, 
a comprehensive search was performed on the subject of training 
medical and paramedical personnel in advanced bleeding control 
options, such as vascular access and REBOA placement.
resulTs
dutch role 2 trauma registry data
During the Dutch deployment to Afghanistan (2006–2010) the 
R2E MTF treated 194 casualties with 307 major haemorrhage 
injuries. There was an average of 1.6 major bleeding sites per 
casualty.9 van Dongen et al analysed potential indications for 
the use of advanced bleeding control options, such as REBOA, 
during the deployment of the Dutch Armed Forces in Afghan-
istan.10 All injuries with major truncal haemorrhage, sustained 
during the deployment to Afghanistan 2006–2010, were iden-
tified and analysed whether they could fit the criteria for use of 
advanced bleeding control options.
There were in total 212 potential indications for advanced 
bleeding control in our cohort with mortality of 28.8% (61/212) 
(Table 1A). These potential indications consisted of 1.9% 
(4/212) junctional lower extremity injuries with a 75% (3/4) 
mortality rate and 59% (125/212) visceral vascular injuries of 
which 12.5% (26/125) casualties did not survive the injury. The 
junctional and visceral injuries (n=129) were all potential indi-
cations for advanced bleeding control options, such as REBOA. 
Further 39.2% (83/212) casualties with central thoracic or neck 
injuries had a mortality rate of 38.6% (32/83). Of the 83 casu-
alties with a central thoracic or neck injury, 11 had associated 
haemorrhage from neck injuries. In total, 61 patients died of 
which three were a result of neck injury.
Potential indications for advanced bleeding control based on 
the AIs and administration of blood products
Casualties with an AIS chest or abdomen score ≥4, indicating a 
severe or critical injury, were identified as potential indication 
for advanced bleeding control, including REBOA. These results 
are demonstrated in Tables 1B,C and show 61 indications for 
advanced bleeding control based on AIS score ≥4. A 24-hour 
average of 8.8 packets of red blood cells (RBC), 4.2 packets of 
plasma and 1.9 packets of platelets was used to prevent exsangui-
nation. The total out-of-hospital survival rate was 64% (39/61).
dIsCussIOn
Retrospective analysis of the Dutch deployment to Afghanistan 
(2006–2010) revealed 212 possible indications for advanced 
bleeding control with a mortality of 28.8% (61/212). Clinical 
outcome might have improved in approximately 212 casualties 
when these severe injuries were treated with advanced bleeding 
control techniques, such as REBOA. Detailed analysis of 61 
casualties revealed a high percentage of casualties (29.3%) that 
needed an average of almost nine packed RBCs during the first 
24 hours of resuscitation with a mortality rate of approximately 
40%. Although tourniquets are useful in preventing exsangui-
nation of a peripheral haemorrhage site, truncal and junctional 
bleeding sites are more difficult to control.11 12 van Oostendorp 
et al1 reviewed available prehospital options for controlling 
life-threatening truncal and junctional haemorrhage. There are 
currently multiple treatment options such as wound clamps, 
injectable haemostatic sponges, pelvic circumferential stabi-
lisers, resuscitative thoracotomy, REBOA, Foley catheter balloon 
tamponade, intra-abdominal gas insufflation, intra-abdominal 
self-expanding foam, junctional and truncal tourniquets. These 
options can be combined as advanced hybrid options in tradi-
tional open surgery to prevent exsanguination. Future research 
should focus on the use of these adjuncts in civilian and mili-
tary austere environments. Besides devices like the aortic clamp, 
junctional tourniquet and foam, REBOA has already been 
used in the earliest phases of prehospital care and in military 
setting.13–15 The pioneering use of this haemorrhage control 
adjunct in the prehospital phase, despite early promising results, 
has not been widely adopted.15 16 In civilian setting, Thabouillot 
et al have evaluated trauma patients registered in the Paris Fire 
Brigade emergency medical system with bleeding of supposedly 
abdominal and/or pelvic and/or junctional origin, uncontrolled 
haemorrhagic shock or cardiac arrest with attempted resuscita-
tion.17 They concluded that 3.2% would have been candidates 
for REBOA and they believe that this intervention should be 
available in the prehospital setting. Barnard et al tried to identify 
the number of patients from England and Wales (2012–2013) 
using the Trauma Audit and Research Network-NHS England 
and Wales trauma database registry, in whom REBOA may have 
reasonably been used. They found that 0.055% of all trauma 
patients had an indication for REBOA with an overall mortality 
of 32%.18
In military setting, Eastridge et al performed an analysis of the 
incidence and causes of potentially preventable deaths among 
US combat fatalities. All battlefield fatalities (2001–2011) 
were reviewed and analysed, 87.3% of all mortality occurred 
in the pre-MTF environment. Of the pre-MTF deaths, 75.7% 
(n=3040) were classified as non-survivable and 24.3% (n=976) 
were deemed potentially survivable. The injury or physiolog-
ical focus of potentially survivable acute mortality was largely 
associated with haemorrhage (90.9%). The site of lethal haem-
orrhage was truncal (67.3%), followed by junctional (19.2%) 
and peripheral extremity (13.5%) haemorrhage.5 This has led to 
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AIS chest ≥4 (n=14) 6.4 (4.7) 4.5 (2–11) 6 (43) 3.1 (3.3) 2 (0–6) 1.4 (1.6) 0.5 (0–3)
AIS abdomen ≥4 (n=34) 9.1 (6.5) 8.5 (4–12) 24 (71) 4.2 (3.9) 3.5 (1–7) 2.0 (1.9) 2 (0–3)
AIS extremity ≥4 (n=15) 11.2 (9.4) 10 (4–16) 10 (67) 5.5 (5.6) 5 (0–7) 2.1 (1.8) 1 (0–3)
Total (n=61*) 8.8 (7.2) 8 (4–12) 38 (63) 4.2 (4.3) 3 (1–7) 1.9 (1.8) 2 (0–3)
*Two patients had combined AIS chest and AIS abdomen ≥4.
AIS, Abbreviated Injury Scale; RBC, red blood cell; REBOA, resuscitative endovascular balloon occlusion of the aorta.
improvements in Tactical Combat Casualty Care guidelines.19 20 
In 2014, Morrison et al analysed severely injured UK combat 
casualties and concluded that 1 in 5 severely injured UK combat 
casualties have a focus of haemorrhage in the abdomen or pelvic 
junctional region potentially amenable to REBOA deploy-
ment.21 Recently, Joseph et al published a nationwide analysis of 
REBOA in civilian trauma patients. A case-controlled retrospec-
tive analysis of the 2015–1026 American College of Surgeons 
data set containing 593 818 patients compared 140 patients in 
the REBOA group with 280 matched patients. They concluded 
that patients in the REBOA group had a higher mortality rate 
compared with the matched non-REBOA patients. Joseph et al 
conclude that there is a need for a concerted effort to clearly 
define when and in which patient population REBOA has 
benefit.22
Preventing exsanguination in military victims in pre-MTF 
setting involves extensive training programmes and readily avail-
able resources. Borger van der Burg et al recently published two 
papers on vascular access and REBOA training in personnel with 
limited or no prior endovascular experience (residents, (mili-
tary) trauma surgeons, Special Forces medics, combat nurses and 
military non-surgeon physicians). These studies showed that a 
comprehensive theoretical and practical training programme can 
be used for percutaneous femoral access and REBOA placement 
training of personnel without prior ultrasound or endovascular 
experience.23 24 These findings are supported by a similar study 
by Pasley et al, in which it is stated that independent duty mili-
tary medical technicians are able to learn and perform REBOA 
correctly and rapidly, but that emphasis on vascular access 
training is important.25 Redman and Ross report on a trans-
portable central-perfused cadaver model suitable for training in 
the battlefield environment on all tactical combat casualty care 
procedures including REBOA.26 Using this model in different 
austere settings, Ross and Redman27 tested two military emer-
gency medicine physicians with no prior endovascular surgery 
exposure on vascular access and REBOA placement. Successful 
placement was accomplished in 86% of the models and percu-
taneous access was successful 54% of the time. They conclude 
that, with proper training, non-surgical providers can properly 
place REBOA catheters in austere prehospital settings at speeds.
There are limitations to this study. The data from the 
registry are retrospective and did not clearly distinguish 
between femoral and junctional injuries. However, based on 
the high transfusion rates and ISS, it was decided that these 
injuries were not manageable with regularly available tourni-
quets and needed advanced bleeding control techniques. Also, 
from the thoracic injuries, 11 had associated neck injuries in 
which REBOA would not have an added value. Furthermore, 
the exact location of bleeding in truncal injuries could not be 
ascertained retrospectively. When truncal injuries cause a major 
bleeding above the left subclavian artery, haemorrhage control 
with REBOA would be ineffective. However, in these injuries 
other advanced bleeding control measures, for instance, the use 
of Foley catheter balloon tamponade, could potentially have 
improved outcome. In a worst-case scenario (when all truncal 
injuries were above the left subclavian artery), REBOA would 
be potentially life-saving in only visceral and junctional injuries, 
being 29 of 129 major bleeding injuries. Another major limita-
tion is that major bleeding is not exclusively associated with 
arterial bleeding. Therefore, REBOA should be labelled as an 
adjunct besides other more effective bleeding control measures 
in venous bleedings.
Achieving vascular access in a haemodynamically unstable 
patient is challenging. Also, the appropriate means of verifying 
the adequate position of the occlusion balloon are often absent 
in the field. Nevertheless, especially in remote and austere 
environments, the extraction times are longer and more unpre-
dictable than in urban settings. Attempting to achieve haemor-
rhagic control with advanced bleeding control adjuncts, such 
as REBOA, is therefore certainly justifiable. Implementation of 
advanced bleeding control adjuncts, such as REBOA, should be 
considered in the military.
COnClusIOn
Retrospective analysis of the Dutch deployment to Afghanistan 
(2006–2010) revealed 212 potential indications for advanced 
bleeding control with a mortality of 28.8% (61/212). Advanced 
bleeding control, such as REBOA, might have improved survival 
in approximately 61 of 212 major haemorrhage casualties. 
Advanced bleeding control could be used as an adjunct to 
improve outcomes in major truncal or junctional haemorrhage 
in a prehospital setting, especially in a remote environment, and 
implementation should be considered. Vascular access training 
and REBOA placement for medical and paramedical military 
personnel should be explored in future research.
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